Objective: To determine patterns of antimicrobial resistance, analyze the prevalence of oxacillinase and molecular typing of strains of Acinetobacter baumannii (A. baumannii).
Therapeutic issues caused by MDR A. baumannii and long-lasting nature in hospital environments and also the ability to transfer between living and non-living things has caused enhancment in the appearance of the bacteria and its increasing infection. Thus, mortality in infections caused by A. baumannii is estimated to be about 75% [5] .
Resistance to carbapenem is now observed globally in A.
baumannii and these isolates are typically resistant to various classes of antibacterial agents. Several outbreaks caused by carbapenem resistant among A. baumannii isolates are reported from different countries of the world which could be an alarm for global health [6] . A. baumannii has different mechanisms for resistance to carbapenems, which include changes in penicillin binding protein, efflux pumps and mostly by production of oxacillinases (OXAs) and less common by metallo β-lactamase (MBLs) genes, AmpC stable derepression and reduced permeability [7, 8] .
The first report of OXA-type beta-lactamases in A. baumannii was related to Acinetobacter resistant to imipenem (ARI-1) that later designated as OXA-23 [4] . Today, OXA-type carbapenemases have eight subgroups, four of which in A. baumannii have been reported:
OXA-23-like consisting of OXA-23, OXA-27 and OXA-49; OXA-24-like (OXA-24, OXA-25, OXA-26, OXA-40 and OXA-72);
OXA-51-like and OXA-58 [9] . The transmission of isolates resistant to carbapenem A. baumannii is shown in the hospital. For control of resistant isolates and epidemiological aims, fast and accurate differentiation of epidemic strains from the many incidental strains is important [10, 11] .
One of the molecular typing methods used to determine the clonal relatedness of A. baumannii is repetitive sequence-based polymerase chain reaction (REP-PCR) [12] . The aim of this study was to survey the antibiotic susceptibility, prevalence of oxacillinase genes and perform molecular typing by REP-PCR in A. baumannii clinical isolates. 
Materials and methods

Ethics statement and informed consent
Study design and specimens collection
This cross-sectional study was performed by using 121 A. and Escherichia coli ATCC 25922 were used as negative controls.
Antibiotic susceptibility testing
PCR amplification and detection of OXA genes
PCR was conducted to detect bla OXA-23-like , bla OXA-24-like , bla OXA-58-like and bla OXA-143-like . All target genes and corresponding primers used for PCR amplification are shown in Table 1 [16] . Bacterial DNA was obtained by boiling method [17] . The PCR mixture contained master Primer 
REP-PCR
Genetic relationship of all isolates was determined by REP-PCR. In the REP-PCR method, the primer pair of REP-F (REP-栺 , 栿 :GCGCCGICATCAGGC) and REP-R (REP-栻 : ACGTCTTATCAGGCCTAC) was used and amplification PCRs were performed as previously described [18] . The amplified products were separated via electrophoresis on 1.5% agarose gels and compared by visual inspection. The amplified products were separated by electrophoresis on 1.2% agarose gel (SinaClon, Iran); after staining with ethidium bromide, they were visualized under UV gel documentation system; then they were photographed and compared together by visual inspection.
Statistical analysis
The results were entered and analyzed using the SPSSTM software, version 22.0 (IBM Corporation, Armonk, NY, USA) and Microsoft Excel 2016 (Microsoft Corporation, USA) statistical software to obtain frequencies and comparison among clones. Chi-square test was applied to analyze intergroup significance. In addition, P< 0.05 was considered statistically significant and the confidence interval was 95%.
Results
Occurrence of A. baumannii
A total of 121 (16.1%) non-duplicate A. baumannii isolates were collected and identified in 750 clinical specimens from different wards of Imam Hossein and Imam Khomeini Hospital in Tehran, Iran. The isolates were obtained from 56 (46.3%) males and 65 (53.7%) females with the mean age of 39.5 years (ranged 9-79 years). The presence of bla OXA-51-like gene was confirmed in all isolates by PCR. The majority of the isolates were collected from intensive care unit (49.6%) and surgery (14.0%), respectively. The frequencies of collected isolates in terms of the hospital ward and clinical samples are mentioned in Table 2 .
Antimicrobial susceptibility rate
The results of susceptibility testing showed that the colistin with 100% sensitivity rate had the highest effect, while ceftriaxone with 16.5% sensitivity rate had the least effect on A. baumannii isolates. The tigecycline with 77.6% sensitivity rate was the second most effective antibiotic after colistin. Additionally, more than 60% of the isolates were resistant against pipracillin/tazobactam, tetracycline, amikacin, cefepime, tobramycin, and ciprofloxacin. Among 121 A. baumannii strains, 96 (79.3%) and 99 (81.8%) isolates were resistant to imipenem and meropenem, respectively. Ninety-six (79.3%) isolates were simultaneously resistant to imipenem and meropenem. In total, 99 (81.8%) of A. baumannii strains were carbapenem resistant. The results of the susceptibility rate of all tested antibiotics are displayed in Table 3 . The results revealed that all A. baumannii strains collected from the trachea, wound, and urine samples were resistant to all antibiotics except for colistin, but the strains isolated from the pleural fluid were susceptible to the majority of antibiotics (Figure 1 ).
Multidrug resistance patterns
MDR isolates were determined based on their resistance to at least one antibiotic in three different antimicrobial categories. A total of 109 isolates (90.0%) were MDR with 10 different resistotypes ( Table 4 ). The R4 with the rate of 24.8% was the most prevalent resistotype.
Molecular characterization of oxacillinase genes
The obtained results from multiplex PCR revealed that 77 (77.7%) isolates of 99 carbapenem resistant A. baumannii had positive PCR band for at least one of bla OXA-like genes. In total, 75 (75.7%) of carbapenem resistant isolates were positive for bla OXA-23-like , and 14 (14.1%) for bla OXA-24-like gene. Meanwhile, the bla OXA-51-like gene was detected in all tested strains. The co-existence of bla OXA-23-like and bla OXA-24-like genes were found in 12 (12.1%) isolates. Finally, the bla OXA-58-like and bla OXA-143-like genes were not detected in any isolates. 
Resistance patterns of blaOXA-like producer A. baumannii isolates
Antibiogram results of bla OXA-like producer and non-producer A.
baumannii isolates are shown in Table 3 . Based on the results, there was a significant difference in the resistance to imipenem, meropenem, ciprofloxacin, and pipracillin/tazobactam antibiotics between bla OXA-like producer and non-producer A. baumannii isolates (Table 5 ).
REP-PCR molecular typing
The molecular typing of 99 carbapenem resistant A. baumannii 
Discussion
Nowadays, A. baumannii has become a global challenge in terms of therapeutic choices due to the resistance to various antibiotics.
Therefore, careful screening of the resistance pattern of this bacterium is very important in health care centers and hospitals. In this study, as expected, similar to previous studies from Iran and different countries, the polymyxins and glycylcycline antibiotic groups were the most effective anti-bacterial drugs against A.
baumannii isolates [19] [20] [21] .
This can be due to the low prescription of these drug categories and their reserve as the last line of infection therapy in our region.
Additionally, the prevalence of resistance rate of polymyxins and glycylcycline among A. baumannii isolates was similar to the global report that mentioned the pooled prevalence of 0.0-3.7 and 2.3-25.8 for colistin and tigecycline, respectively [22] . Also, similar to studies reported by Shoja et al. [19] and Sarikhani et al. [23] from Iran, a high resistance rate above 80% was seen against thirdgeneration cephalosporins in our study.
Resistance to carbapenems in A. baumannii strains is an increasingly remarkable phenomenon leading to limitation of treatment choices. Several reports from different regions of Iran indicated a trend toward increasing resistance to carbapenems in clinical isolates of A. baumannii [24] . In the current study, the results of antibiogram revealed that 18.2% of A. baumannii isolates were susceptible to carbapenems which was in line with other studies from different geographic regions of the world that reported an 8%-26% susceptibility rate for imipenem among A. baumannii isolates [25] .
The high resistance rate of A. baumannii isolates against meropenem (81.8%) and imipenem (79.3%) in current study was consistent with previous studies from Iran [18, 22] . In a recent study by Mobasseri et al. [26] from Iran a resistance rate of 96% were reported against both imipenem and meropenem antibiotics in clinical isolates of A. baumannii.
These findings reflect the fact that the prescription of aforementioned antibiotics for the treatment of infections caused by the A. baumannii should be done with caution and based on the results of in vitro antimicrobial susceptibility testing. Another finding of the current study was the high percentage (90%) of multi-drug resistance among A. baumannii isolates, which confirmed the results of other studies from around the world [27, 28] . 
Conclusion
The main aim of this study was to achieve a baseline background to determine the resistant pattern of oxacillinase producing A.
baumannii in clinical samples. Result from this study affords valuable knowledge to perform further large prospective study to identify the other mechanisms involved in carbapenem resistant A.
baumannii isolates. The OXA-23 was the main oxacillinase that contributed to carbapenem resistance in our study. Observing the high frequency of multiple drug resistant A. baumannii isolates in this study, highlighted the need for continuous and regularly monitoring of antibiotic resistance patterns of these bacteria in our region to control the spread of MDR pathogens in the healthcare facilities.
